E-LIB Suche - Ergebnisse für: Larghero, Patrizia

1

Measurable residual disease quantification in adult patient..:

Burmeister, Thomas ; Ströh, Aeint-Steffen ; Kehden, Britta...
Leukemia. 38 (2024) 7 - p. 1600-1603 , 2024

Link: https://doi.org/10.1038/..

2

Erratum to: Genomic breakpoint-specific monitoring of measu..:

Maurer-Granofszky, Margarita ; Köhrer, Stefan ; Fischer, Susanna...
Haematologica. 109 (2024) 7 - p. 2379-2381 , 2024

Link: https://doi.org/10.3324/..

3

Genomic breakpoint-specific monitoring of measurable residu..:

Maurer-Granofszky, Margarita ; Kohrer, Stefan ; Fischer, Susanna...
Haematologica. 109 (2023) 3 - p. 740-750 , 2023

Link: https://doi.org/10.3324/..

4

P337: IKZF1 DELETIONS IN B-ALL: FROM ITS GENETIC BASIS TO D..:

Lopes, Bruno A. ; Meyer, Claus ; Bouzada, Heloysa...
HemaSphere. 7 (2023) S3 - p. e5507229 , 2023

Link: https://doi.org/10.1097/..

5

The EGR3 regulome of infant KMT2A-r acute lymphoblastic leu..:

Külp, Marius ; Larghero, Patrizia ; Alten, Julia...
Leukemia. 37 (2023) 6 - p. 1216-1233 , 2023

Link: https://doi.org/10.1038/..

6

The recombinome of IKZF1 deletions in B-cell precursor ALL:

Lopes, Bruno A. ; Meyer, Claus ; Bouzada, Heloysa...
Leukemia. 37 (2023) 8 - p. 1727-1731 , 2023

Link: https://doi.org/10.1038/..

7

3109 – IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR G..:

Külp, Marius ; Larghero, Patrizia ; Alten, Julia...
Experimental Hematology. 124 (2023) - p. S104 , 2023

Link: https://doi.org/10.1016/..

8

The immune checkpoint ICOSLG is a relapse-predicting biomar..:

Külp, Marius ; Siemund, Anna Lena ; Larghero, Patrizia...
iScience. 25 (2022) 7 - p. 104613 , 2022

Link: https://doi.org/10.1016/..

9

Vaccine-induced COVID-19 mimicry syndrome:

Krutzke, Lea ; Kowarz, Eric ; Külp, Marius...
eLife. 11 (2022) - p. , 2022

Link: https://doi.org/10.7554/..

10

Therapy-related acute myeloid leukemia with KMT2A-SNX9 gene..:

Sardou-Cezar, Ingrid ; Lopes, Bruno A. ; Andrade, Francianne Gomes...
Cancer Genetics. 256-257 (2021) - p. 86-90 , 2021

Link: https://doi.org/10.1016/..

11

KMT2A-ARHGEF12, a therapy related fusion with poor prognosi:

Assaf, Nada ; Liévin, Raphael ; Merabet, Fatiha...
Molecular Biology Reports. 48 (2021) 10 - p. 7021-7027 , 2021

Link: https://doi.org/10.1007/..

12

KMT2A-CBLrearrangements in acute leukemias: clinical charac..:

Bataller, Alex ; Guijarro, Francesca ; Caye-Eude, Aurélie...
Blood Advances. 5 (2021) 24 - p. 5617-5620 , 2021

Link: https://doi.org/10.1182/..

13

Human MLL/KMT2A gene exhibits a second breakpoint cluster r..:

Meyer, Claus ; Lopes, Bruno A. ; Caye-Eude, Aurélie...
Leukemia. 33 (2019) 9 - p. 2306-2340 , 2019

Link: https://doi.org/10.1038/..

14

Activating Killer Immunoglobulin Receptors and HLA-C: a suc..:

Malnati, Mauro S. ; Ugolotti, Elisabetta ; Monti, Maria Cristina...
Scientific Reports. 7 (2017) 1 - p. , 2017

Link: https://doi.org/10.1038/..

15

Dose-responsiveness and persistence of microRNA expression ..:

Izzotti, Alberto ; Larghero, Patrizia ; Longobardi, Mariagrazia...
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 717 (2011) 1-2 - p. 9-16 , 2011

Link: https://doi.org/10.1016/..